This topic contains a solution. Click here to go to the answer

Author Question: When a perfectly competitive firm or a monopolistically competitive firm is making zero economic ... (Read 113 times)

a0266361136

  • Hero Member
  • *****
  • Posts: 538
When a perfectly competitive firm or a monopolistically competitive firm is making zero economic profit,
 a. no firms will want to enter or exit.
  b. some firms will want to leave.
  c. some firms will want to enter.
  d. market demand shifts to the left.
  e. the price of the output will rise in the long run.

Question 2

Explicit costs would include:
 a. rent.
  b. the interest loss of the business owner on money withdrawn from his/her saving account and invested in the business.
  c. the loss of rent on a building the business owner owns and uses in his/her business.
  d. the opportunity costs of the business owner's time.
  e. the use of tools owned by the business owner and dedicated to the business.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

wtf444

  • Sr. Member
  • ****
  • Posts: 314
Answer to Question 1

a

Answer to Question 2

a





 

Did you know?

The Babylonians wrote numbers in a system that used 60 as the base value rather than the number 10. They did not have a symbol for "zero."

Did you know?

Most fungi that pathogenically affect humans live in soil. If a person is not healthy, has an open wound, or is immunocompromised, a fungal infection can be very aggressive.

Did you know?

Eating carrots will improve your eyesight. Carrots are high in vitamin A (retinol), which is essential for good vision. It can also be found in milk, cheese, egg yolks, and liver.

Did you know?

Acetaminophen (Tylenol) in overdose can seriously damage the liver. It should never be taken by people who use alcohol heavily; it can result in severe liver damage and even a condition requiring a liver transplant.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library